Grand Pharmacology Bundle 2023

Anxiety Pharmacotherapeutics

There are a variety of anxiety disorders being managed in the primary care setting.  This program presents the physiology of anxiety disorders as a foundation for pharmacologic management, key features in differentiating among anxiety disorders, and pharmacologic choices for acute and chronic management.

Credits: 1.50 contact hours; 1.50 are pharmacology

Cardiovascular

pharmacology updates

This session will review foundational principles of cardiovascular pharmacology and include both new medications and updated indications for cardiovascular medications. Discussion will focus on medications used in the treatment of heart failure, coronary artery disease, atrial fibrillation and deep vein thrombosis.

Credits: 1.50 contact hours; 1.50 are pharmacology

Case Studies in Mood Disorders

Using case studies from both primary care and the mental health care settings, managing the plan of care is analyzed using mood stabilizer, antipsychotic, and antidepressant therapies to achieve best patient outcomes. Differentiating among medications in the same class as well as utilization of best combination therapies is discussed.

Credits: 1.50 contact hours; 1.50 are pharmacology

Clostridioides Difficile Treatment Updates

This presentation will review the updated CDI recommendations and assess the emerging literature surrounding factors influencing the optimal pharmacologic management of initial CDI and recurrent CDI. The presentation will also review considerations for probiotic co-administration as a CDI preventative in patients prescribed antibiotics.

Credits: 1.50 contact hours; 1.50 are pharmacology

Anemia/Hematology

An understanding of basic hematology is essential to diagnosing and treating common conditions like anemia. Identifying the presence of anemia is the first step in the management of this condition. This presentation will discuss red blood cell production, common anemia etiologies, identification of anemia type from hemograms, management and evaluation of treatment.

Credits: 1.00 contact hours; 0.5 are pharmacology

Alzheimer’s disease is the most common cause of dementia. The etiology is unknown and there is no known cure for this devastating progressive neurodegenerative disease. The hippocampus is affected and prevents the patient from forming new memories. The patient often recognizes it but doesn’t want to talk about the “hippo” in the room. 

Credits: 1.0 contact hours; 0.33 are pharmacology

Parkinson’s Disease is a common neurologic disorder. Early recognition and treatment is key to slowing the progressive disability that occurs as a result of decreased dopamine. Primary care providers are key to recognizing signs and symptoms of Parkinson’s Disease early.

Credits: 1.0 contact hours; 0.65 are pharmacology

The purpose of this presentation is to provide NPs an update on the treatment of patients with HIV. It will include an overview of the issues that have impacted the uptake and use of PrEP, the newest medications available for treatment, and a brief discussion on the impact of the end the epidemic initiatives. This accredited session is made available through support from Gilead Sciences.

Credits: 1.00 contact hours; 1.00 are pharmacology

This series uses the NPACE augmented reality application to supplement learning in case studies, heart sounds, and heart structures. This bundle will help the NP through the basics of EKG interpretation, advanced cardiac assessment, cardiac test ordering and interpretation, and the basics for cardiology in primary care.

Total Credits: 4.75 contact hours; 0.0 are pharmacology